Surgical Mesh And Sling Devices Must Undergo Post-Market Studies
This article was originally published in The Gray Sheet
Executive Summary
FDA sends post-market study orders to 33 manufacturers of urogynecologic surgical mesh used for pelvic organ prolapse and to seven makers of single-incision mini-slings used for stress urinary incontinence.